




版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
1、我国结核病的疫情状况 who 93年宣布“全球结核病紧急状态”,98年又重申遏制结核病的行动刻不容缓。 全球现有结核病人2000万,其中95在发展中国家,每年还会新发生800-1000万肺结核病,其中75的病人年龄在1550岁。如不控制,今后10年还将有9000万人发病。 中国是全球22个结核病高负担国家之一,结核病人数位居世界第二位,仅次于印度. 据调查全国三分之一的人口已感染了结核菌;受感染人数超过4亿,受结核感染人群中有10的人发生结核病1tuberculosis factor of tuberculosis incidence rising : hiv spread. tb strai
2、n occur drug resistance . fluid population increasing. management tb patient not perfect、prevention and cure not efficiency. poverty、population increasing.2etiology mycobacterium 、 acid fastness、g+、aerobe。 growth torpidity , culture need 4-6 weeks. typing : human type 、 bovine type 、 bird type、mouse
3、 type 、 main human type。 way of infection:respiration tract、digestive track、skin or placenta.3epidemiology 1 infection sources:open pulmonary tuberculosis 2 route of transmission: by respiration way or digestion tract. 3 susceptible population4epidemiology the factors lead children ill with tb conta
4、ct tb amounts and toxicity. power of resistance . hereditary factor .5pathogenesybacterial number、toxicity、immunization condition cell-mediated immune reaction:macrophage swallow tbantigen presentation th and macrophageil12cd+4th1-if-to promote mononuclear cell; to gather、activation、proliferation an
5、d differentiationto produce alexin and oxidase 、 digestive enzymeto kill tb6pathogenesy if-reinforcement cd+8 、nk cells activity to phagocytosis tb. meanwhile to lead histoclasia delayed allergy : t cell media,macrophage to be effector cell,to kill reinfection tb and cause cheesy necrosis or hole fo
6、rmation after infection tb : primary disease(5%),secondary disease (5%), not to fall ill all live(90%)7 diagnose objective to discover focal 。 definite disease character、size whether or not deliver bacterium。8diagnose 1 history tb toxic symptom to contact tb patient bcg vaccination acute infection:m
7、easles,pertussis supersensitivity erythema nodosum、exanthematous conjunctivitis。9diagnose 2 :ot test agent:1/2000 or 1/10000 ppd dose:0.1ml(ot 5u)(or 1u)。 position:left forearm palmaris below 1/3 infuse intracutaneous form 6-10mm hillock。 4872hr observation reaction。10diagnosis reaction 5mm(-) 5mm(+
8、) 10-19mm(+) 20mm(+) super reaction :induration、vesic 、 local ulceration (+)。11diagnosis significance positive reaction after bcg vaccination older children positive reaction indicate to be ever infected with tb before。 infant never bcg vaccination indicate new infection recent。 strong positive reac
9、tion indicate there is activeness tb.。 from(-)to(+)、from 10mm ,or increase 6mm by activeness tb.。12diagnosis negative reaction never infection tb first infect tb during 4-8 weeks false negative reaction,immune function to be pressed down。 wrong with test or ppd ineffective13diagnosis bcg vaccination
10、 and natural infection positive reaction conditionresult infectionbcg vaccinationextent(1015mm) (59mm)to changeslowly (710d)faster 23ddurationto last lifetimeto last 34 yearsformdeep red hardred soft14diagnosis3 : laboratory examination(1)find tb specimen:sputum、gastric juice、c.s.f、serous cavity liq
11、uid. method:smear、 fluorescent staining、 bactec system:culture for 2 weeks,test mycobacteria metabolism production,to distinguish tb and atypical .mycobacteria. l tubercle bacterium:mutation tb,form、construction、acid-fast staining different from common tb。easy passing placenta,therapeutic inefficacy
12、。15diagnosis(2)immunology and molecular biology test elisa(酶联免疫吸附试验) eliep(酶联免疫电泳技术) dna探针 pcr (聚合酶链式反应) 线条dna探针杂交试验 esr (血沉)。16diagnosis4 : chest x-ray to definite focus of infection position 、extent、category、activity condition。 to evaluate and follow up therapeutic efficacy 。 ct more clear to find
13、 the focus、 extent and spread condition。5:bronchofiberscopy check:to definite endotracheal membrane tb and tuberculosis of trachebronchial lymph nodes。6:lymph node puncture smear or lymphaden biopsy to diagnosis。17tuberculotherapy general treatment nutrition、to take a rest。 avoiding to contact infec
14、tion disease 。 primarily tb treatment in out-patient clinic and regularity return visit 。 report epidemic situation。18tuberculotherapy treatmen target to kill bacillus tuberculosis in focus to prevent disseminate。 therapeutic principle early treatment reasonable dosage combine medicine regularity ta
15、ke drug to insist on whole course segmenting treatment.19tuberculotherapy anti-tuberculosis drugs whole germicide:in acid and alkali,exterior and interior of cell can kill germ。(inh rfp) half germicide:in acid or alkali environment kill cell interior or exterior tb,sm /pza bacteriostatic:emb(ethambu
16、tol) eth(ethionamide)20tuberculotherapy new antituberculosis to anti drug resistant rifamate(contain inh 150mg rfp300mg) rifater(inh,rfp pza) old drug derivant:rifapentine new chemicals:dipasic,to delay resistant inh drug standard treatment: refer to asymptomatic primarily pulmonary tuberculosis usa
17、ge:inh+rfpemb course of treatment 912 month.21化疗方案 two stage therapy refer to:activeness primarily pulmonary tb: acute miliary tuberculosis;brain tb; intensification therapy:(purpose) combination 34 germicide drugs longer 34mo、shorter 2mo。 continue treatment stage combination two drugs to keep thera
18、peutic effect for 1218mo.(longer rang)or 4mo. (short-rang) 。22化疗方案 short-range therapy who important strategy to cure tuberculosis mechanism of action is fast kill organism inner cell or out cell。 to sputum bacterium(-),recovery fast ,recurrence less。 2hrz/4hr、2shrz/4hr、2ehrz/4hr23antituberculosis d
19、rugsmedicine dose adverse reaction inh 1020 多发性神经炎,肝损害rfp 1015 可逆性肝损害,消化道症状。尿红色。pza 20-30 肝损害,高尿酸血症。sm 1520 听神经损害,肾损害。emb 1520 球后视神经炎。 24tuberculosis prevention to control source of infection:smear(+) patient pervasion bcg vaccination:to have an inoculation age is neonate. contraindicationcellular immunity deficiencyacute infectious disease convalescence stageregion eczema or general skin diseaseot(+)25tuberculosis preventiondrug prevention indication: 1 close to contact open pulmonary
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025版金融投资合伙经营退伙协议书
- 2025年度石油钻井平台电工外包及设备检修服务合同
- 二零二五年度禁止放牧技术培训与服务合同
- 2025年度城市配送大货车运输服务合同模板
- 二零二五年度跨区域建筑垃圾集中运输及资源化利用服务协议
- 2025版城市公共供水服务合同模板
- 2025版纺织品跨境电商代理销售合同
- 二零二五年度高端家具框架销售合同范本
- 二零二五年度科研机构间实验场地租赁合同
- 二零二五年度国际贸易融资借款合同
- 企业工伤预防培训课件
- 新疆伊犁州高校毕业生“三支一扶”计划招募笔试真题2024
- 2025汽车智能驾驶技术及产业发展白皮书
- 网络安全部门四讲四有问题查摆清单及整改措施
- 食品安全总监、食品安全员考核考试试题库(含答案)
- 知识产权大数据分析-洞察阐释
- 《电力建设火力发电厂工程智慧工地技术标准》
- 电梯故障救援培训
- 职称评审申报培训
- 2025-2030中国凹版印刷机市场动向追踪及运行态势分析报告
- 设计院建筑管理制度
评论
0/150
提交评论